Developing guidelines in musculoskeletal disorders

Clinical and Experimental Rheumatology

Volumn 25, Issue 6 SUPPL. 47, 2007, Pages

  Lopez Olivo, Maria A ^a   Suarez Almazor, Maria E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Clinical practice guidelines; Quality indicators; Quality of care

Indexed keywords

CORTICOSTEROID; METHOTREXATE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ANKYLOSING SPONDYLITIS; ARTICLE; CONSENSUS DEVELOPMENT; CORTICOSTEROID INDUCED OSTEOPOROSIS; EVIDENCE BASED MEDICINE; FIBROMYALGIA; GOUT; HEALTH CARE QUALITY; HUMAN; INTERNET; JUVENILE RHEUMATOID ARTHRITIS; LIVER TOXICITY; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL SOCIETY; METHODOLOGY; MUSCULOSKELETAL DISEASE; OSTEOARTHRITIS; OSTEOPOROSIS; PATIENT DECISION MAKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT PLANNING; VALIDITY;

HUMANS; MUSCULOSKELETAL DISEASES; PRACTICE GUIDELINES AS TOPIC; QUALITY INDICATORS, HEALTH CARE; RHEUMATOLOGY;

EID: 36448965678     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. WOOLF SH, GROL R, HUTCHINSON A, ECCLES M, GRIMSHAW J: Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318: 527-30.
2. FIELD MJ and LOHR KN (Eds.): Clinical Practice Guidelines: Directions for a New Program. Institute of Medicine, Washington, DC, National Academy Press, 1990.
3. HOMIK JE, SUAREA-ALMAZOR ME: Clinical guidelines: a must for rheumatology? Bailières Best Pract Res Clin Rheumatol 2000; 14: 649-61.
4. WOOLF SH: Do clinical practice guidelines define good medical care? The need for good science and the disclosure of uncertainty when defining 'best practices'. Chest 1998; 113 (Suppl.): 166S-71S.
5. HUTTIN C: The use of clinical guidelines to improve medical practice: Main issues in the United States. Int J Qual Health Care 1997; 9: 207-14.
6. BRAGATO LT JACOBS K: Care pathways: the road to better health services? J Health Organ Manag 2003; 17: 164-80.
7. WOOLF SH: Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. Arch Intern Med 1992; 152: 946-52.
8. ATKINS D, BEST D, BRISS PA, ECCLES M et al.: Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490.
9. EDDY DM: Clinical deFision-making: from theory to practice. Practice policies - guidelines for methods. JAMA 1990; 263: 1839-41.
10. EDDY DM: Clinical deFision-making: from theory to practice. Guidelines for policy statements: The explicit approach. JAMA 1990; 263: 2239-40, 2243.
11. KOZMA CM: The National Guideline Clearinghouse. Managed Care Interface 2006; 19: 43, 51.
12. NATIONAL GUIDELINE CLEARINGHOUSE: Links to Guidelines Resources. Agency for Healthcare Research and Quality 2007. Available: http://www.guideline.gov/resources/guideline resources.aspx (accessed 2007 Jul 02).
13. RYAN S, BROWNE A, HOME D, WILD A, HENNELL S, HOMER D: Benchmarking the nurse consultant role in rheumatology. Nurs Stand 2006; 20: 52-7.
14. ELLIS J:ABenchmarking: a way of universalising the best. Nursing Times Research 2001; 6: 566-7.
15. PANTALL J: Benchmarking in healthcare. Nursing Times Research 2001; 6: 568-80.
16. WOOLF SH: The need for perspective in evidence-based medicine. JAMA 1999; 282: 2358-65.
17. CLUZEAU F AND THE AGREE COLLABORATION: Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project. Qual Saf Health Care 2003; 12: 18-23.
18. SHEKELLE PG, WOOLF SH, ECCLES M, GRIMSHAW J: Clinical guidelines: Developing guidelines. BMJ 1999; 318: 593-6.
19. Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument. The AGREE Collaboration 2001. Available: http://www.agreecollaboration.org/ (accessed 2007 Apr 10).
20. SIGN 50: A Guideline Developers' Handbook, Scottish Intercollegiate Guidelines Network 2001 (accessed 2007 May 17).
21. AMERICAN COLLEGE OF RHEUMATOLOGY AD HOC COMMITTEE ON IMMUNOLOGIC TESTING GUIDELINES: Guidelines for immunologic laboratory testing in the rheumatic diseases: An introduction. Arthritis Rheum 2002: 47: 429-33.
22. SIMON LS, LIPMAN AG, JACOX AK et al.: Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis and Juvenile Chronic Arthritis, 2nd. ed., Glenview, IL, American Pain Society (APS), 2002.
23. BRIGHAM AND WOMEN'S HOSPITAL: Lower Extremity Musculoskeletal Disorders. A Guide to Diagnosis and Treatment. Boston, MA, Brigham and Women's Hospital, 2003.
24. INSTITUTE FOR CLINICAL SYSTEMS IMPROVEMENT (ICSI): Adult Low Back Pain. Bloomington, MN, Institute for Clinical Systems Improvement, 2006.
25. KREMER JM, ALARCON GS, LIGHTFOOT RW JR et al.: Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 1994; 37: 316-28.
26. AMERICAN COLLEGE OF RHEUMATOLOGY AD HOC COMMITTEE ON CLINICAL GUIDELINES: Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996; 39: 713-22.
27. AMERICAN COLLEGE OF RHEUMATOLOGY AD HOC COMMITTEE ON CLINICAL GUIDELINES: Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 1996; 39: 723-31.
28. NEWSOME G and the AMERICAN COLLEGE OF RHEUMATOLOGY: Guidelines for the management of rheumatoid arthritis: 2002 update. Journal of the American Academy of Nurse Practitioners (JAANP) 2002; 14: 432-7.
29. AMERICAN COLLEGE OF RHEUMATOLOGY SUBCOMMITTEE ON RHEUMATOID ARTHRITIS GUIDELINES: Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002; 46: 328-46.
30. NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (NICE): Final Appraisal Determination. Anakinra for Rheumatoid Arthritis. London, UK, July 2003.
31. OTTAWA PANEL: Ottawa Panel evidence-based clinical practice guidelines for electrotherapy and thermotherapy interventions in the management of rheumatoid arthritis in adults. Phys Ther 2004; 84: 1016-43.
32. OTTAWA PANEL: Ottawa Panel evidence-based clinical practice guidelines for therapeutic exercises in the management of rheumatoid arthritis. Phys Ther 2004; 84: 934-72.
33. COMBE B, LANDEWÉ R, LUCAS C et al.: EULAR recommendations for the management of early arthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007; 66: 34-45.
34. CASSIDY J, KIVLIN J, LINDSLEY C, NOCTON J, the SECTION ON RHEUMATOLOGY and the SECTION ON OPHTHALMOLOGY: Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 2006; 117: 1843-5.
35. AMERICAN COLLEGE OF RHEUMATOLOGY SUBCOMMITTEE ON OSTEOARTHRITIS GUIDELINES: Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000; 43: 1905-15.
36. PENDLETON A, ARDEN N, DOUGADOS M et al.: EULAR recommendations for the management of knee osteoarthritis: Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000; 59: 936-44.
37. SCHNITZER TJ and the AMERICAN COLLEGE OF RHEUMATOLOGY: Update of ACR guidelines for osteoarthritis: Role of the coxibs. J Pain Symptom Manage 2002; 23 (Suppl.): S24-30; discussion S31-4.
38. JORDAN KM, ARDEN NK, DOHERTY M et al.: EULAR Recommendations 2003: an evidence-based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) Ann Rheum Dis 2003; 62: 1145-55.
39. AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS: AAOS Clinical Practice Guideline on Osteoarthritis of the Knee. Rosemont, IL, American Academy of Orthopaedic Surgeons, 2003.
40. AMERICAN ACADEMY OF ORTEOPAEDIC SURGEONS: AAOS Clinical Practice Guideline on Osteoarthritis of the Knee (Phase II). Rosemont, IL, American Academy of Orthopaedic Surgeons, 2003.
41. AMERICAN COLLEGE OF RADIOLOGY EXPERT PANEL ON MUSCULOSKELETAL IMAGING: Chronic Hip Pain. Reston, VA, National Guideline Clearinghouse, 2003.
42. WASHINGTON STATE DEPARTMENT OF LABOR AND INDUSTRIES: Review criteria for knee surgery. Provider Bull, 2003.
43. INSTITUTE FOR CLINICAL SYSTEMS IMPROVEMENT (ICSI): Diagnosis and Treatment of Adult Degenerative Joint Disease of the Knee. Bloomington, MN, Institute for Clinical Systems Improvement, 2004.
44. NATIONAL INSTITUTES OF HEALTH (NIH): Consensus Development Panel on Total Knee Replacement. Final Statement. Rockville, MD, U.S. Department of Health and Human Services (DHHS), 2004.
45. OTTAWA PANEL: Ottawa Panel evidence-based clinical practice guidelines for therapeutic exercises and manual therapy in the management of osteoarthritis. Phys Ther 2005; 85: 907-71.
46. ZHANG W, DOHERTY M, ARDEN N et al.: EULAR evidence-based recommendations for the management of hip osteoarthritis: Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005; 64: 669-81.
47. MICHIGAN QUALITY IMPROVEMENT CONSORTIUM: Medical Management of Adults with Osteoarthritis. Southfield, MI, Michigan Quality Improvement Consortium, 2005.
48. UNIVERSITY OF MICHIGAN HEALTH SYSTEM: Knee Pain or Swelling: Acute or Chronic. Ann Arbor, MI, University of Michigan Health System, 2005.
49. ZHANG W, DOHERTY M, LEEB BF et al.: EULAR evidence-based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007; 66: 377-88.
50. AMERICAN COLLEGE OF RHEUMATOLOGY TASK FORCE ON OSTEOPOROSIS GUIDELINES: Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1996; 39: 1791-801.
51. AMERICAN COLLEGE OF RHEUMATOLOGY TASK FORCE ON OSTEOPOROSIS: ACR recommendations target prevention and treatment of glucocorticoid-induced osteoporosis. Am Fam Physician 1997; 55: 1450, 1453.
52. HODGSON SF, WATTS NB, BILEZIKIAN JP et al.: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 2003; 9: 544-64.
53. AMERICAN COLLEGE OF RHEUMATOLOGY AD HOC COMMITTEE ON GLUCOCORTICOID-INDUCED OSTEOPOROSIS: Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 2001; 44: 1496-503.
54. Selective Estrogen Receptor Modulators. Washington, DC, American College of Obstetricians and Gynecologists (ACOG), 2002.
55. Osteoporosis. Singapore, Singapore Ministry of Health, 2002.
56. AMERICAN GASTROENTEROLOGICAL ASSOCIATION MEDICAL POSITION STATEMENT: Guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 2003; 124: 791-4.
57. AMERICAN GASTROENTEROLOGICAL ASSOCIATION MEDICAL POSITION STATEMENT: Osteoporosis in hepatic disorders. Gastroenterology 2003; 125: 937-40.
58. Osteoporosis. Columbia, MD, American Medical Directors Association, 2003.
59. HILLNER BE, INGLE JN, CHLEBOWSKI RT et al.: American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003; 21: 4042-57.
60. Physician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC, National Osteoporosis Foundation, 2003.
61. Health Professional's Guide to Rehabilitation of the Patient with Osteoporosis. Washington, DC, National Osteoporosis Foundation, 2003.
62. Management of Osteoporosis. A National Clinical Guideline. Edinburgh (Scotland), Scottish Intercollegiate Guidelines Network (SIGN), 2003.
63. BERG AO: Screening for osteoporosis in postmenopausal women: recommendations and rationale. Am J Nurs 2003; 103: 73-80.
64. Diagnosis of osteoporosis in men, premenopausal women and children. J Clin Densitom 2004; 7: 17-26.
65. Bisphosphonates (Alendronate, Etidronate, Risedronate), Selective Oestrogen Receptor Modulators (Raloxifene) and Parathyroid Hormone (Teriparatide) for the Secondary Prevention of Osteoporotic Fragility Fractures in Postmenopausal Women. London, UK, National Institute for Clinical Excellence (NICE), 2005.
66. Osteoporosis: Prevention and Treatment. Ann Arbor, MI, University of Michigan Health System, 2005.
67. MANAGEMENT OF OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN: 2006 position statement of The North American Menopause Society. Menopause 2006; 13: 340-67.
68. THE ROLE OF CALCIUM IN PERI- AND POST-MENOPAUSAL WOMEN: 2006 position statement of the North American Menopause Society. Menopause 2006; 13: 862-77.
69. INSTITUTE FOR CLINICAL SYSTEMS IMPROVEMENT (ICSI): Diagnosis and Treatment of Osteoporosis. Bloomington, MIN, Institute for Clinical Systems Improvement, 2006.
70. MICHIGAN QUALITY IMPROVEMENT CONSORTIUM: Management and Prevention of Osteoporosis. Southfield, MI, Michigan Quality Improvement Consortium, 2006.
71. ZOCHLING J, VAN DER HEIJDE D, BURGOS-VARGAS R et al.: ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006; 65: 442-52.
72. Fibromyalgia. Olympia, WA, Washington State Department of Labor and Industries, 2002.
73. GOLDENBERG DL, BURCKHARDT C, CROFFORD L: Management of fibromyalgia syndrome. JAMA 2004; 292: 2388-95.
74. FAMILY NURSE PRACTITIONER PROGRAM: Fibromyalgia Treatment Guideline. Austin, TX, University of Texas, School of Nursing, 2005.
75. BUCKHARDT CS, GOLDENBERG D, CROFFORD L et al.: Guideline for the Management of Fibromyalgia Syndrome Pain in Adults and Children. American Pain Society (APS), 2005.
76. ZHANG W, DOHERTY M, PASCUAL E et al.: EULAR evidence-based recommendations for gout. Part I. Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 1301-11.
77. ZHANG W, DOHERTY M, BARDIN T et al.: EULAR evidence-based recommendations for gout. Part II. Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 1312-24.
78. AMERICAN COLLEGE OF RHEUMATOLOGY AD HOC COMMITTEE ON SYSTEMIC LUPUS ERYTHEMATOSUS GUIDELINES: Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum 1999; 42: 1785-96.
79. SOLOMON DH, KAVANAUGH AJ, SCHUR PH and the AMERICAN COLLEGE OF RHEUMATOLOGY AD HOC COMMITTEE ON IMMUNOLOGIC TESTING GUIDELINES: Evidence-based guidelines for the use of immunologic tests: Antinuclear antibody testing. Arthritis Rheum 2002: 47: 434-44.
80. Systemic lupus erythematosus (SLE). In EBM Guidelines. Helsinki, Finland, Duodecim Medical Publications, 2006.
81. Etanercept and Infliximab for the Treatment of Adults with Psoriatic Arthritis. London, UK, National Institute for Health and Clinical Excellence (NICE), 2006.
82. AYMERICH M, SANCHEZ E: [From scientific knowledge of clinical research to the bedside: Clinical practice guidelines and their implementation]. Gac Sanit 2004; 18: 326-34.